UBS Maintains Neutral on Albemarle, Lowers Price Target to $137
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has maintained a Neutral rating on Albemarle (NYSE:ALB) and reduced the price target from $142 to $137. This adjustment reflects a more conservative valuation of the company's stock by UBS.

January 30, 2024 | 5:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS has maintained a Neutral rating on Albemarle and lowered the price target from $142 to $137, indicating a cautious outlook on the stock's value.
The reduction in price target by a major analyst like UBS suggests a more conservative view on Albemarle's future stock performance, which could lead to a negative short-term impact on the stock price as market participants adjust their valuations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100